STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Completed
- Cancer of Prostate
- Observation and Bicalutamide
- Metformin and Bicalutamide
- Bethesda, Maryland
- +1 more
2022-03-02
Mar 2, 2022U
Withdrawn
- COVID-19
- Bicalutamide 150 Mg Oral Tablet
- Placebo
- (no location specified)
2021-06-30
Jun 30, 2021S
Terminated
- Covid19
- +2 more
- Camostat Mesilate
- Bicalutamide 150 mg
- Baltimore, MarylandJohns Hopkins Hospital
2021-09-15
Sep 15, 2021A
Recruiting
- Prostate Adenocarcinoma
- bicalutamide
- Stereotactic body radiation therapy
- Bethesda, MarylandNational Cancer Institute
2021-10-01
Oct 1, 2021I
Recruiting
- Breast Cancer
- Metastasis
- Abemaciclib
- Bicalutamide
- New York, New York
- +2 more
2021-10-14
Oct 14, 2021P
Recruiting
- Breast Neoplasm Female
- +3 more
- Nivolumab
- +2 more
- Portland, OregonProvidence Oncology & Hematology Care Clinic - Eastside
2022-01-31
Jan 31, 2022S
Terminated
- Metastatic Triple Negative Breast Cancer
- TPC
- Bicalutamide 150 mg
- Guangzhou, Guangdong, China
- +1 more
2021-01-26
Jan 26, 2021M
Active, not recruiting
- Metastatic Breast Cancer (MBC)
- Palbociclib
- Bicalutamide
- Basking Ridge, New Jersey
- +4 more
2021-10-29
Oct 29, 2021M
Completed
- Breast Cancer
- bicalutamide
- +2 more
- San Francisco, California
- +7 more
2021-06-25
Jun 25, 2021A
Recruiting
- Prostate Adenocarcinoma
- Lower Urinary Tract Symptoms
- Bicalutamide implant
- Wahroonga, New South Wales, Australia
- +3 more
2021-01-13
Jan 13, 2021K
Active, not recruiting
- Triple Negative Breast Cancer
- ribociclib
- Bicalutamide
- Chicago, Illinois
- +4 more
2022-02-16
Feb 16, 2022S
Withdrawn
- COVID-19
- SARS-CoV 2
- Bicalutamide 150 Mg Oral Tablet
- Baltimore, MarylandJohns Hopkins Hospital
2021-03-02
Mar 2, 2021B
Active, not recruiting
- Adenocarcinoma of the Prostate
- +2 more
- enzalutamide
- +5 more
- Birmingham, Alabama
- +3 more
2021-03-02
Mar 2, 2021U
Completed
- Breast Cancer
- Bicalutamide
- FDHT PET
- Groningen, NetherlandsUniversity Medical Center Groningen
2019-11-26
Nov 26, 2019M
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +3 more
- (no location specified)
2022-01-05
Jan 5, 2022S
Recruiting
- Salivary Gland Neoplasms
- Pyrotinib
- +2 more
- Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
2021-10-08
Oct 8, 2021M
Recruiting
- Prostate Cancer
- Triptorelin Embonate
- Bicalutamide 50 mg
- Brescia, BS, ItalyASST Spedali Civili of Brescia
2021-10-29
Oct 29, 2021U
Active, not recruiting
- Prostatic Neoplasms
- hypoxia measurement
- Toronto, Ontario, CanadaPrincess Margaret Hospital
2021-10-01
Oct 1, 2021U
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +3 more
- Chicago, IllinoisUniversity of Chicago
2021-09-30
Sep 30, 2021S
Active, not recruiting
- Prostate Cancer
- Leuprolide Acetate
- +4 more
- Washington, District of Columbia
- +1 more
2022-03-29
Mar 29, 2022U
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiosurgical Boost
- +2 more
- Sacramento, CaliforniaUC Davis Sacramento Cancer Center Dept of Radiation Oncology
2021-09-24
Sep 24, 2021M
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +7 more
- Milwaukee, WisconsinFroedtert Hospital
2021-02-17
Feb 17, 2021U
Active, not recruiting
- Prostate Cancer
- Docetaxel
- +3 more
- Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
2021-12-27
Dec 27, 2021S
Active, not recruiting
- Prostate Cancer
- Leuprolide Acetate
- +4 more
- Washington, District of Columbia
- +2 more
2021-10-11
Oct 11, 2021R
Completed
- Prostate Cancer
- bicalutamide
- +4 more
- Toronto, Ontario, CanadaToronto Sunnybrook Regional Cancer Centre
2020-10-21
Oct 21, 2020